edited by J. Stanton King, Jr. (Foreword by Harold W. Glattly), 712 pp, 246 illus, $18.50, Boston: Little, Brown & Co., 1967.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This handsome cloth-bound volume contains proceedings of the First International Symposium on Renal Neoplasia. At that gathering, held in Brazil in the fall of 1965, 52 participants (46 of them from the United States) gave 26 papers and joined in five panel discussions.
The resulting book concerns mostly renal cell carcinoma—what causes it, how it manifests itself, what diagnostic tests yield information, what factors govern prognosis, and how surgery, irradiation, and chemotherapy can best be used to give desirable results. Only a few scattered pages appear on nephroblastomas (Wilms' tumors) and transitional cell carcinomas.
What the authors say indicates to me that, although much has been studied, little has changed. Renal cell carcinomas still comprise about 3% of all cancers; they still often grow unnoticed in the retroperitoneal space until too late; they remain puzzling diagnostic problems; renal vein invasion and metastatic spread continue to be the only reliable prognostic
Reech RL. Renal Neoplasia. JAMA. 1967;202(2):158. doi:10.1001/jama.1967.03130150126047